Recent data suggest that by PET tau depositions can also be discerned in atypical parkinsonian disorders (Coakeley and Strafella, 2015), and in PSP in particular (Chiotis et al., 2016; Hammes et al., 2016). This evidence concerns the gene MAPT and supranuclear palsy, progressive, 1.